- 专利标题： Heterocyclic inhibitors of ATR kinase
-
申请号： US17009428申请日： 2020-09-01
-
公开(公告)号： US11434233B2公开(公告)日： 2022-09-06
- 发明人: Maria Emilia Di Francesco , Philip Jones , Christopher Lawrence Carroll , Jason Bryant Cross , Suyambu Kesava Vijayan Ramaswamy , Michael Garrett Johnson , Sarah Lively , David Lapointe
- 申请人： Board of Regents, The University of Texas System , ChemPartner Corporation
- 申请人地址： US TX Austin; US CA South San Francisco
- 专利权人： Board of Regents, The University of Texas System,ChemPartner Corporation
- 当前专利权人： Board of Regents, The University of Texas System,ChemPartner Corporation
- 当前专利权人地址： US TX Austin; US CA South San Francisco
- 代理商 Dennis A. Bennett; Lauren L. Stevens; Cynthia Hathaway
- 主分类号： C07D413/14
- IPC分类号： C07D413/14 ; C07D413/04 ; C07D411/14 ; C07D471/04 ; C07D417/14 ; A61K45/06 ; A61P35/00
摘要：
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
公开/授权文献
- US20210047311A1 HETEROCYCLIC INHIBITORS OF ATR KINASE 公开/授权日：2021-02-18
信息查询
